Increasing Healthcare Expenditure in Light of the COVID-19 Outbreak will Create Opportunities for the Use of Dehydrated Alcohol as a Solvent and Reagent

Introduction

Increasing healthcare spending around the world is expected to increase the demand for dehydrated alcohol. While many countries were already increasing their healthcare spending, the COVID-19 outbreak has intensified the focus more than ever before. In light of the pandemic, countries are likely to undergo rigorous changes in healthcare spending, creating opportunities for the dehydrating alcohol market. Dehydrated alcohol has significant applications as an antiseptic while administering injections and in treating several neurological disorders. Most of its raw material is either sourced from China or the U.S., where the COVID-19 impact is severe. Disruptions in the global supply chain are expected to adversely impact market growth.

Other applications, such as chemical and industrial, where dehydrated alcohol is used as solvent or reagent are also facing the brunt of COVID-19, with supply chain disruption as the foremost issue. The U.S., Germany, and China are the leading producers of chemicals in the world and striving to come up with different strategies to fulfill the local demand for dehydrated alcohol. The world post-COVID-19 will be a different world where protectionist policies will likely be on the rise, creating demand-supply fallouts and resulting in price fluctuations.

Competitive Players

Key Players

• Millipore Sigma
• Spectrum Chemical Mfg. Corp.
• Ricca Chemical Company
• Mitsubishi Chemical Company
• Cargill Corp.
• Decon Labs
• Honeywell International Inc.
• Fisher Scientific
• Fujifilm
• Nacalai Tesque, Inc.
• Xuzhou First Chemical Co., Ltd.

Recent Developments

Segmentation

Dehydrated Alcohol Market: Segmentation

By Source

• Grains
• Sugarcane
• Corn
• Fossil fuels
• Others

By Application

• Solvent
• Cleaner
• Reagent
• Additive

By End-User

• Life Sciences
• Industrial
• Automobile
• Others